Please Wait
Applying Filters...
menu
    • menu
    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-05-19

    Virtual Booth

    An Enquiry

    Chirogate is a professional Prostaglandin manufacturer.

    Virtual Booth

    Contact Supplier

    Temad- We think of world-class quality.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-04-28

    Virtual Booth

    An Enquiry

    Menu

    Taladegib

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Endeavor BioMedicines Names ILD Expert Lisa Lancaster CMO
    Endeavor BioMedicines Names ILD Expert Lisa Lancaster CMO

    02 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250402562765/en/Endeavor-BioMedicines-Appoints-Internationally-Renowned-ILD-Expert-Lisa-Lancaster-M.D.-as-Chief-Medical-Officer

    BUSINESSWIRE
    02 Apr 2025
    Share Share
    Endeavor BioMedicines Completes Enrollment in Phase 2a Clinical Trial of ENV-101
    Endeavor BioMedicines Completes Enrollment in Phase 2a Clinical Trial of ENV-101

    06 Sep 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230906375636/en

    BUSINESSWIRE
    06 Sep 2023
    Share Share
    Endeavor Doses First Patient in Phase 2 Oncology Study of ENV-101 (Taladegib)
    Endeavor Doses First Patient in Phase 2 Oncology Study of ENV-101 (Taladegib)

    25 May 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220525005283/en

    BUSINESSWIRE
    25 May 2022
    Share Share
    Endeavor Bio Closes $101M Series B Financing for Precision Medicine Pipeline
    Endeavor Bio Closes $101M Series B Financing for Precision Medicine Pipeline

    07 Feb 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220207005151/en

    BUSINESSWIRE
    07 Feb 2022
    Share Share
    Endeavor BioMedicines Doses First Patient in Phase 2 of Taladegib for IPF
    Endeavor BioMedicines Doses First Patient in Phase 2 of Taladegib for IPF

    22 Sep 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210922005035/en

    BUSINESSWIRE
    22 Sep 2021
    Share Share